Jones Financial Companies
RYTM icon

Jones Financial Companies’s Rhythm Pharmaceuticals RYTM Stock Holding History

Jones Financial Companies’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
12,066
+7,148
+145% +$646K ﹤0.01% 1753
2026
Q1 		$373K Buy
4,918
+4,687
+2,029% +$456K ﹤0.01% 2174
2025
Q4 		$24.7K Sell
231
-3
-1% -$318 ﹤0.01% 2842
2025
Q3 		$23.2K Buy
234
+3
+1% +$279 ﹤0.01% 2712
2025
Q2 		$14.5K Hold
231
– – ﹤0.01% 2730
2025
Q1 		$12.7K Hold
231
– – ﹤0.01% 2610
2024
Q4 		$12.9K Hold
231
– – ﹤0.01% 2421
2024
Q3 		$11.9K Hold
231
– – ﹤0.01% 2161
2024
Q2 		$9.48K Buy
+231
New +$9.22K ﹤0.01% 1776

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jones Financial Companies's RYTM Position: Q2 2026 in Review

Jones Financial Companies increased its Rhythm Pharmaceuticals (RYTM) stake by 145% in Q2 2026, buying an estimated $646K and bringing the position to 12,066 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Jones Financial Companies first reported a position in RYTM in Q2 2024 and has held it in 9 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Jones Financial Companies held 12,066 shares of Rhythm Pharmaceuticals worth $1.33M as of Q2 2026.
  • Jones Financial Companies bought 7,148 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $646K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1753 holding.
  • Jones Financial Companies first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.